Asset Details
Do you wish to reserve the book?
Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States
Do you wish to request the book?
Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States
2022
Overview
Abstract
A large, ongoing multicountry outbreak of human monkeypox has the potential to cause considerable morbidity and mortality. Therapeutics for the treatment of smallpox, a related Orthopoxvirus, may be used and affect the natural history of monkeypox. We present 3 patients from our hospitals treated with tecovirimat, a pan-Orthopoxvirus inhibitor currently available under an expanded access investigational new drug protocol for monkeypox.
Publisher
Oxford University Press
Subject
